Subcutaneous panniculitis‐like T‐cell lymphoma post‐mRNA‐1273 COVID‐19 vaccination

Abstract

This is a case of subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) was diagnosed by skin biopsy in a patient who presented with fever and erythema nodosum in the umbilicum following mRNA‐1273 COVID‐19 vaccination. COVID‐19 vaccines may cause SPTCL and skin biopsy may help in the diagnosis of erythema nodosum.

A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature

“…The Pfizer/BioNTech vaccine appears to be the most implicated (16 cases). The onset of symptoms following vaccine inoculation has generally been very brief, even within a few days, as seen for instance in the cases reported by Kreher et al, Ukishima et al and Panou et al [44,45,47]. In one case, acute lymphoblastic leukemia occurred in a 47-year-old woman who had been in remission for two years from a B-cell lymphoma [39].…”

“…The development and widespread use of modRNA vaccines have raised significant concerns globally, leading to adverse events and complications in both healthy individuals and those with preexisting conditions. Reports of increased cases of a variety of cancers [18], including highly aggressive cancers, termed "Turbo Cancer" [20] and the unexpected recurrence of cancers after decades of remission, have been independently noted by oncology experts and researchers worldwide, with several publications supporting these observations [35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51]. Understanding the mechanisms behind the carcinogenic effects of the modRNA COVID-19 vaccines is crucial.…”

A Case Report of Acute Lymphoblastic Leukaemia (ALL)/Lymphoblastic Lymphoma (LBL) Following the Second Dose of Comirnaty®: An Analysis of the Potential Pathogenic Mechanism Based on of the Existing Literature

“…The Pfizer/BioNTech vaccine appears to be the most implicated (16 cases). The onset of symptoms following vaccine inoculation has generally been very brief, even within a few days, as seen for instance in the cases reported by Kreher et al, Ukishima et al and Panou et al [44,45,47]. In one case, acute lymphoblastic leukemia occurred in a 47-year-old woman who had been in remission for two years from a B-cell lymphoma [39].…”

“…The development and widespread use of modRNA vaccines have raised significant concerns globally, leading to adverse events and complications in both healthy individuals and those with preexisting conditions. Reports of increased cases of a variety of cancers [18], including highly aggressive cancers, termed "Turbo Cancer" [20] and the unexpected recurrence of cancers after decades of remission, have been independently noted by oncology experts and researchers worldwide, with several publications supporting these observations [35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51]. Understanding the mechanisms behind the carcinogenic effects of the modRNA COVID-19 vaccines is crucial.…”